Cormorant Asset Management, LP 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
CA
Cormorant Asset Management, LP
Institutional Filer 12.87%$1.99B46

Current Portfolio Holdings

Showing all 46 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1PRAXPraxis Precision Medicines, Inc.Healthcare886K$285.3M14.33%
2BBOTBridgeBio Oncology Therapeutics Inc.Healthcare17.9M$160.0M8.04%
3EYPTEyePoint Pharmaceuticals, Inc.Healthcare8.3M$106.5M5.35%
4EWTXEdgewise Therapeutics, Inc.Healthcare3.3M$102.7M5.16%
5ERASErasca, Inc.Healthcare5.8M$93.8M4.71%
6RAPPRapport Therapeutics, Inc. Common StockHealthcare3.0M$92.5M4.65%
7ALMSAlumis Inc. Common StockHealthcare3.9M$87.0M4.37%
8ABVXAbivax S.A.Healthcare760K$84.6M4.25%
9MLTXMoonLake ImmunotherapeuticsHealthcare4.5M$83.5M4.19%
10DNTHDianthus Therapeutics, Inc.Healthcare950K$79.7M4.00%
11DRUGBright Minds Biosciences Inc.Healthcare1.1M$77.3M3.88%
12OLMAOlema Pharmaceuticals, Inc.Healthcare4.4M$65.6M3.29%
13BBIOBridgeBio Pharma, Inc.Healthcare850K$63.1M3.17%
14BIOABioAge Labs, Inc.Healthcare2.9M$50.6M2.54%
15CNTACentessa Pharmaceuticals plcHealthcare1.1M$41.7M2.09%
Showing 1 to 15 of 46 holdings